• OPEN AN ACCOUNT
Indian Indices
Nifty
22,402.40 34.40
(0.15%)
Sensex
73,852.94 114.49
( 0.16%)
Bank Nifty
48,189.00 218.55
( 0.46%)
Nifty IT
33,442.55 -272.00
( -0.81%)
Global Indices
Nasdaq
15,696.64 245.33
(1.59%)
Dow Jones
38,503.69 263.71
(0.69%)
Hang Seng
17,201.27 372.34
(2.21%)
Nikkei 225
38,460.08 907.92
(2.42%)
Forex
USD-INR
83.39 -0.03
(-0.04%)
EUR-INR
88.83 -0.06
(-0.06%)
GBP-INR
103.02 -0.17
(-0.16%)
JPY-INR
0.54 0.00
(-0.10%)

EQUITY - MARKET SCREENER

Glaxosmithkline Pharmaceuticals Ltd
Industry :  Pharmaceuticals - Multinational
BSE Code
ISIN Demat
Book Value()
500660
INE159A01016
91.3566062
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
GLAXO
51.78
32909.66
EPS(TTM)
Face Value()
Div & Yield %
37.52
10
1.65
 

Inani Securities reports standalone net loss of Rs 0.09 crore in the March 2023 quarter
May 27,2023
Net loss of Inani Securities reported to Rs 0.09 crore in the quarter ended March 2023 as against net profit of Rs 0.01 crore during the previous quarter ended March 2022. Sales declined 40.00% to Rs 0.21 crore in the quarter ended March 2023 as against Rs 0.35 crore during the previous quarter ended March 2022.

For the full year,net profit rose 15.38% to Rs 0.45 crore in the year ended March 2023 as against Rs 0.39 crore during the previous year ended March 2022. Sales declined 47.24% to Rs 1.05 crore in the year ended March 2023 as against Rs 1.99 crore during the previous year ended March 2022.

ParticularsQuarter EndedYear Ended
 Mar. 2023Mar. 2022% Var.Mar. 2023Mar. 2022% Var.
Sales0.210.35 -40 1.051.99 -47
OPM %-100.0017.14 --81.9022.61 -
PBDT0.030.08 -63 -0.350.81 PL
PBT-0.150.01 PL -0.680.52 PL
NP-0.090.01 PL 0.450.39 15